X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 63 filers reported holding X4 PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,345 | -52.5% | 11,326 | -15.5% | 0.00% | – |
| Q2 2023 | $25,996 | +116.6% | 13,400 | +841.7% | 0.00% | – |
| Q1 2021 | $12,000 | +33.3% | 1,423 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | -10.0% | 1,423 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -41.2% | 1,423 | -23.5% | 0.00% | – |
| Q2 2020 | $17,000 | -19.0% | 1,861 | -21.5% | 0.00% | – |
| Q1 2020 | $21,000 | -22.2% | 2,372 | -4.8% | 0.00% | – |
| Q4 2019 | $27,000 | +8.0% | 2,492 | +25.8% | 0.00% | – |
| Q3 2019 | $25,000 | +47.1% | 1,981 | +70.0% | 0.00% | – |
| Q2 2019 | $17,000 | +750.0% | 1,165 | +782.6% | 0.00% | – |
| Q1 2019 | $2,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |